BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $88,000 | +17.3% | 25,673 | -1.9% | 0.00% | 0.0% |
| Q3 2019 | $75,000 | +2400.0% | 26,173 | +4101.1% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 623 | +27.4% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 489 | +25.7% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 389 | -20.4% | 0.00% | – |
| Q3 2018 | $4,000 | +100.0% | 489 | +25.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 389 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 389 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -96.6% | 389 | -98.1% | 0.00% | -100.0% |
| Q2 2016 | $58,000 | +100.0% | 20,389 | +96.3% | 0.00% | 0.0% |
| Q1 2016 | $29,000 | +625.0% | 10,389 | +2570.7% | 0.00% | – |
| Q4 2015 | $4,000 | 0.0% | 389 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | -96.4% | 389 | -94.7% | 0.00% | -100.0% |
| Q2 2015 | $110,000 | +214.3% | 7,389 | +90.0% | 0.00% | +100.0% |
| Q1 2015 | $35,000 | -18.6% | 3,889 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $43,000 | +48.3% | 3,500 | +16.7% | 0.00% | 0.0% |
| Q3 2014 | $29,000 | -23.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $38,000 | +375.0% | 3,000 | +200.0% | 0.00% | – |
| Q4 2013 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | -83.7% | 1,000 | -96.4% | 0.00% | -100.0% |
| Q2 2013 | $43,000 | – | 28,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |